Institut Bergonié

corporate_fareorganization

Institut Bergonié

- Funding / Projects
  (107)

107 Projects, page 1 of 22

Phase II multicenter study evaluating the efficacy and safety of XL184 (Cabozantinib) in patients pre-treated for locally advanced and/or metastatic osteosarcoma or Ewing's sarcoma
assignment_turned_inProjectUntil 2018Partners:Institut Bergonié
Institut Bergonié
Funder: Institut National du Cancer Project Code: INCa-11387
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line
assignment_turned_inProjectPartners:Groupe Hospitalier Pitié Salpétrière, ICM-VAL D'AURELLE, Centre Hospitalier Régional et Universitaire de Lille, Délégation à la Recherche et à lInnovation - CHU Angers, Centre Léon Bérard +17 partners
Groupe Hospitalier Pitié Salpétrière,
ICM-VAL D'AURELLE,
Centre Hospitalier Régional et Universitaire de Lille,
Délégation à la Recherche et à lInnovation - CHU Angers,
Centre Léon Bérard,
CHUG,
Institut Bergonié,
Hôpital Côte de Nacre,
Hôpital Jean Minjoz,
Polyclinique de Courlancy,
Centre Hospitalier de Colmar,
Hôpital Central,
Hôpital Dupuytren,
Délégation à la Recherche Clinique et à Iinnovation - CHRU de Brest,
CHUAP,
Hôpital le Bocage,
Centre Hospitalier Universitaire de Rennes,
Hôpital de Rangueil,
Centre Henri Becquerel,
Centre Hospitalier Universitaire de Tours,
Hôpital René Huguenin - Institut Curie,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-7342
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder
assignment_turned_inProjectPartners:Centre François Baclesse, Centre Léon Bérard, Institut Bergonié, Hôpital Saint-Louis, Institut Curie +6 partners
Centre François Baclesse,
Centre Léon Bérard,
Institut Bergonié,
Hôpital Saint-Louis,
Institut Curie,
Centre Hospitalier Universitaire de Rouen,
HUS,
Institut de cancérologie Lucien Neuwirth,
Institut Paoli-Calmettes- (IPC),
Institut Claudius Regaud,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-3712
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Caractéristiques épidémiologiques détaillées des Hémopathies lymphoïdes en France en 2006-2008
assignment_turned_inProject2008 - 2011Partners:Institut Bergonié, Hôpital Côte de Nacre, Service de Biostatistique des Hospices Civils de Lyon, CHU Dijon-Bourgogne - Centre Hospitalier Universitaire de Dijon, Faculté de médecine
Institut Bergonié,
Hôpital Côte de Nacre,
Service de Biostatistique des Hospices Civils de Lyon,
CHU Dijon-Bourgogne - Centre Hospitalier Universitaire de Dijon,
Faculté de médecine
Funder: Institut National du Cancer Project Code: INCa-700
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
METROmaJX: Phase Ib/II study of metronomic cyclophosphamide and oncolytic poxvirus JX-594 in advanced breast cancer and soft tissue sarcoma
assignment_turned_inProjectUntil 2019Partners:Institut Bergonié
Institut Bergonié
Funder: Institut National du Cancer Project Code: INCa-7484
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Institut Bergonié

Institut Bergonié

107 Projects, page 1 of 22

Phase II multicenter study evaluating the efficacy and safety of XL184 (Cabozantinib) in patients pre-treated for locally advanced and/or metastatic osteosarcoma or Ewing's sarcoma

BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line

Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder

Caractéristiques épidémiologiques détaillées des Hémopathies lymphoïdes en France en 2006-2008

METROmaJX: Phase Ib/II study of metronomic cyclophosphamide and oncolytic poxvirus JX-594 in advanced breast cancer and soft tissue sarcoma

Loading